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Abstract 
There are a number of studies examining clinical and comorbidity profiles among patients with treatment-resistant obsessive-
compulsive disorder (TR-OCD); however, there have been far fewer investigations of neurocognitive function among such 
patients.  Five patients with treatment-refractory obsessive-compulsive symptoms underwent neurocognitive and 
clinical/personality testing.  A number of TR-OCD patients met diagnostic criteria for major axis I disorders (particularly mood 
and anxiety disorders) as well as clusters A, B, and C personality disorders. TR-OCD patients demonstrated significant 
performance deficits on neurocognitive tests of visuospatial working memory, visuoconstructive ability, and executive control as 
well as one test of processing speed, but not a second, relative to healthy normative controls. TR-OCD patients and normative 
controls did not differ significantly on measures of verbal working memory, sequencing, figure copy organization, inhibitory 
control, and odor identification.  In addition, TR-OCD patients were directly compared to five healthy controls evaluated in our 
laboratory for a separate unpublished study. TR-OCD patients demonstrated significant performance deficits on tests of 
visuospatial working memory, information processing speed, and executive control, and obtained substantially higher scores on 
dimensional measures of social anxiety and depressive symptom severity, but not schizotypal personality features. Group 
differences of tests of verbal working memory, inhibitory control, and additional tests of executive function were not significant.  
In summary, patients with TR-OCD presented with comorbid axis I conditions (primarily mood and anxiety disorders) and 
personality disorders.  TR-OCD patients demonstrated deficits on some, but not all, tests of working memory and executive 
control.  Neurocognitive test findings lend partial support to the hypothesis that right hemisphere (particularly dorsolateral-
prefrontal, but not orbitofrontal) dysfunction is associated with TR-OCD, and a number of TR-OCD patients met diagnostic 
criteria for major axis I disorders (particularly mood and anxiety disorders) as well as cluster A, B, and C personality disorders 
further complicating treatment. 
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1. Introduction 
 
There are a number of studies examining clinical and comorbidity profiles among patients with treatment-resistant 
obsessive-compulsive disorder (TR-OCD).  TR-OCD is associated with a broad spectrum of psychiatric syndromes. 
However, there have been far fewer investigations of neurocognitive function among such patients. In the present 
study, patients with longstanding treatment-refractory obsessive-compulsive symptoms underwent neurocognitive 
and clinical/personality testing. 
 
The principal objective of the present study was to establish a neurocognitive/clinical profile for patients with TR-
OCD in order to more fully understand the phenomenon of treatment resistance.   We will also test the hypothesis 
that TR-OCD patients will demonstrate performance deficits on frontal executive control tasks and a task considered 
to be a sensitive indicator of orbitofrontal dysfunction (e.g., an odor identification task). 
 
2. Methods 
 
Five right-handed patients (2 male, 3 female) with treatment-refractory obsessive-compulsive symptoms underwent 
neurocognitive and clinical/personality testing.  Study inclusion criteria were:  a primary diagnosis of OCD; history 
of psychotherapy and medication treatment failure; and the ability to provide informed consent.  
 
All five TR-OCD patients were screened by psychiatrists at a major psychiatric hospital in Istanbul, Turkey and had 
a primary diagnosis of OCD. All patients had demonstrated treatment resistance and were receiving medication at 
the time of testing.  Medications included clomipramine, fluvoxamine, sertraline, fluoxetine, aripiprazole, 
quetiapine, buspirone, and hydroxyzine.   Informed consent was obtained from all patients and control subjects.   
The present study was approved by the Institutional Review Board at the Istanbul University School of Medicine.  
 
2.1. Clinical measures 
 
Clinical measures included Turkish versions of the Mini International Neuropsychiatric Interview (MINI) (Ornek & 
Keskiner, 1998), SCID-II-PQ (Sorias et al., 1990), Obsessive-Compulsive Inventory (OCI) (Turkish translation), 
Beck Depression Inventory (BDI) (Hisli, 1988), Liebowitz Social Anxiety Scale (LSAS)(Soykan, Ozguven, & 
Gencoz, 2003), Schizotypal Personality Questionnaire-B (SPQ-B) (Aycicegi, Dinn, & Harris, 2005), and the Frontal 
Lobe Personality Scale(Aycicegi, Dinn, & Harris, 2003).  
 
Turkish translations of the aforementioned measures were based on the original English-language instruments 
including the Frontal Lobe Personality Scale (Grace & Malloy, 1992), Obsessive-Compulsive Inventory (Foa et al., 
1998), Schizotypal Personality Questionnaire-B (Raine & Benishay, 1995). 
 
2.2. Neurocognitive tests 
 
The neurocognitive test battery included measures of information processing speed (Digit Symbol Coding and 
Symbol Search tests from the Wechsler Adult Intelligence Scale-IV, Wechsler, 2008), visuoconstructive ability 
(Rey Complex Figure Test (RCFT) copy accuracy), verbal working memory (Turkish version of the Letter-Number 
Sequencing Test based on ) and visuospatial working memory (Spatial Span from the Wechsler Memory Scale-III, 
Wechsler, 1997), executive and inhibitory control (Turkish version of the Trail Making Test based on Reitan & 
Wolfson 1985;Turkish translation of Color-Word Interference Testfrom the Delis-Kaplan Executive Function 
System (D-KEFS), Delis, Kaplan, & Kramer, 2001; Design Fluency Test from the D-KEFS, Delis et al., 2001; Rey 
Complex Figure Test copy organization), and an odor identification task (Brief Smell Identification Test-Turkish 
version, Doty, 2001). The scoring protocol described by Savage and coworkers (1999) was used to determine 
whether the subject copied the Rey complex geometric figure in an organized fashion (6-point copy organization 
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scoring system). The Ishihara Test for Color Blindness was also administered to TR-OCD patients and healthy 
controls since the Color-Word Interference Test requires intact color vision.  The 3rd and 4th conditions of the Color-
Word Interference Test assess inhibitory control. 
 
2.3. Data analysis plan 
 
TR-OCD patients’ scores on dimensional measures of psychiatric symptoms and related personality characteristics 
as well as performance on neurocognitive tests were compared to healthy Turkish normative controls (i.e., 
community-dwelling healthy controls).It is important to note that several different normative control groups were 
used for different neurocognitive tests and, in our analyses of covariance, degrees of freedom vary according to how 
many healthy control subjects completed the test.  
 
The Mann-Whitney U-test was to determine whether groups differed on the aforementioned clinical measures.  For 
a number of measures, TR-OCD patients were directly compared to five right-handed healthy controls (2 male, 3 
female) evaluated at Istanbul University for a separate unpublished study.  Healthy controls were free of neurologic 
(based on screening interview) and psychiatric (as determined by the MINI) disorders including substance abuse, 
did not report a history of traumatic head injury, and were not medicated at the time of testing.  TR-OCD and 
healthy control groups did not differ significantly on age, educational level, handedness, or gender composition; 
however, mean age of control subjects was approximately three years younger than TR-OCD patients (see Table 3).  
Age and educational level were controlled during direct comparisons (analysis of covariance-ANCOVA).  
Comparisons of patients with TR-OCD and normative controls are presented in Tables 1 and 2, while comparisons 
of TR-OCD patients and five healthy controls are shown in Tables 3 and 4.    
 
3. Results 
 
Mean age of the patient sample was 37.8 years (SD = 13.2) ranging from 26 to 60.  TR-OCD patients had completed 
9.4 years of formal education (SD = 4.9) ranging from 5 to 16 years. Mean duration of OCD symptoms was 16.2 
years (SD = 10.9).   
 
3.1. Axis-I disorders 
 
Structured psychiatric interview (MINI) at the time of testing revealed that TR-OCD patients met diagnostic criteria 
for obsessive-compulsive disorder (5 / 5), major depression current (2 / 5), major depression lifetime (3 / 5), 
dysthymic disorder current (2 / 5), agoraphobia current (3 / 5), agoraphobia lifetime but not current (1 / 5), substance 
abuse (alcohol) (1 / 5), generalized anxiety disorder current (4 / 5), and psychotic disorder current (1 / 5).  TR-OCD 
patients did not fulfill criteria for panic disorder (current or lifetime), social anxiety disorder, post-traumatic stress 
disorder, or non-alcohol substance abuse.   
 
3.2. Personality disorders 
 
A self-report measure of axis-II disorders (SCID-II-PQ) revealed that TR-OCD patients met criteria for the 
following personality disorders: schizotypal (3 / 5), paranoid (3 / 5), schizoid (3 / 5), avoidant (5 / 5), dependent (2 / 
5), obsessive-compulsive (3 / 5), narcissistic (2 / 5), borderline (3 / 5), histrionic (3 / 5), and antisocial (1 / 5).    
 
3.3. Dimensional measures of psychiatric symptoms 
TR-OCD patients obtained significantly higher scores on dimensional self-report questionnaires assessing OCD (U 
= 31.5, p= .001), depressive (U = 75.0, p< .001), and social anxiety symptoms relative to healthy community-
dwelling normative controls free of psychiatric and neurologic disease (see Table 1 for group means and SD).  Mean 
Beck Depression Inventory (BDI) score among TR-OCD patients was 27.8 (SD = 12.9), a moderate-to-severe level 
of symptom intensity. Groups differed on OC symptom clusters (i.e., symptom frequency over the past month) 
including obsessional thinking (U = 12.5, p< .001), compulsive washing (U = 46.5, p = .004), checking (U = 72.0, p 
= .03), mental neutralizing (U = 36.5, p = .001), doubting (U = 34.5, p = .001), hoarding (U = 73.5, p = .032), and 
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total OCI frequency (U = 31.5, p= .001).  However, group differences on the ordering subscale did not reach 
significance (U = 89.0, p = .078).    
 
TR-OCD patients also scored higher on a measure of schizotypal personality features (SPQ-total); however, group 
differences were not significant (U = 126.0,p = .35).  Interestingly, 3 of 5 TR-OCD patients had markedly elevated 
scores on the SPQ-B, while the remaining two obtained low scores well below the general population mean. 
Table 1. Dimensional Measures of Psychiatric Symptoms: Group Means (SD) 
 
Measure TR-OCD Normative Control 
 
OCI-Total Frequency 
 
87.0 (27.0) 
 
37.9 (22.7) 
OCI-Obsessional Thinking 16.8 (5.2) 5.2 (4.4) 
OCI-Compulsive Washing 
OCI-Checking 
OCI-Mental Neutralizing 
OCI-Ordering 
OCI-Doubting 
OCI-Hoarding 
SPQ-B-Total  
BDI-Total 
 
18.6 (8.0) 
17.0 (7.8) 
10.6 (3.8) 
12.0 (5.1) 
6.0 (1.7) 
6.0 (4.7) 
11.4 (8.3) 
27.8 (12.9) 
7.6 (5.6) 
8.7 (6.2) 
4.6 (3.1) 
7.6 (4.4) 
2.3 (2.4) 
1.6 (1.9) 
7.3 (4.0) 
7.1 (4.4) 
 
Note. OCI =Obsessive-Compulsive Inventory; SPQ-B = Schizotypal Personality Questionnaire-B; BDI = Beck Depression 
Inventory. 
 
3.4. Neurocognitive tests 
 
Although TR-OCD and normative control groups did not differ significantly on age or education (normative control 
age range was 26-60), the TR-OCD patients were somewhat younger (non-significant difference).  Therefore, age 
was controlled during comparisons of neurocognitive task performance (analysis of covariance-ANCOVA). 
 
TR-OCD and normative control groups did not obtain significantly different scores on instruments assessing of 
verbal working memory (Letter Number Sequencing, F(1,354) = 2.9, p = .08), visuospatial working memory 
(Spatial Span forward and total, F(1,349)= 0.25, p = .61 and F(1,349) = 3.04, p = .08).  TR-OCD patients did obtain 
significantly lower scores on Spatial Span backwards (F(1,349) = 5.27, p = .022), the task which places greater 
demands on visuospatial working memory. 
 
TR-OCD patients did differ significantly from normative controls on one measure of processing speed (WAIS-IV 
Symbol Search, F(1,21) = 17.03, p< .001), but not a second (WAIS-IV Digit Symbol Coding, F(1,21) = 2.81, p = 
.108), with patients obtaining lower scores relative to normative controls on both tasks (see Table 2 for group means 
and SD).  TR-OCD patients obtained significantly lower scores on a measure of visuoconstructive ability (RCFT 
copy accuracy, F(1,354) = 4.51, p = .034); however, group differences on visuoconstructive organization did not 
reach significance (RCFT copy organization, F(1,354)= 3.62, p = .058) (see Table 2).  Group differences on a test of 
inhibitory control (3rd and 4th conditions of the Color-Word Interference) were not significant with F(1,16) = 0.29, p 
= .59 and F(1,16) = 0.43, p = .51, respectively. 
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Relative to healthy normative control subjects, TR-OCD patients demonstrated performance deficits on a test of 
executive control.  Groups did not differ on Trails part A completion time (F(1,66) = 1.5, p = .21) and Trails part A 
number of sequencing errors (F(1,66) = 0.6, p = .44), a task that draws on visuospatial scanning, graphomotor, and 
sequencing skills.  Group differences on Trails part B were striking (Trails B completion time, F(1,66) = 33.2, p< 
.001 and Trails B sequencing errors, F(1,66) = 38.8, p<.001).  Groups did not, however, differ on Trails B loss set 
errors (F(1,66) = 0.02, p = .86).  In addition to the aforementioned skills, Trails B also draws on working memory 
and set-shifting skills. 
 
TR-OCD patients did not demonstrate impaired task performance (mean percentile rank = 55th) on the odor 
identification task, a measure considered to be a sensitive indicator of orbitofrontal dysfunction.  Indeed, no patient 
obtained a score in the impaired range using published normative data (Doty, 2001).  Since Turkish normative data 
were not available for this task, we employed published normative data. 
Table 2. Neurocognitive Tests and Self-Report Measures of Dysexecutive Behavior: Group Means (SD) 
 
Measure TR-OCD Normative Control 
 
Spatial Span Forward 
 
7.2 (1.3) 
 
7.5 (1.7) 
Spatial Span Backward 4.2 (2.5) 6.0 (2.0) 
Spatial Span Total 
Letter-Number Sequencing 
Digit Symbol Coding 
Symbol Search 
Trail Making Test (part A) Time 
Trail Making Test (part A) Seq. Errors 
Trail Making Test (part B) Time 
Trail Making Test (part B) Seq. Errors 
Trail Making Test (part B) LOS Errors 
RCFT copy accuracy 
RCFT copy organization 
Color-Word Interference Test 1 Time 
Color-Word Interference Test 2 Time 
Color-Word Interference Test 3 Time 
Color-Word Interference Test 4 Time 
FLPS-Executive Dysfunction 
FLPS-Disinhibition 
FLPS-Apathy 
 
11.4 (3.0) 
7.8 (4.4) 
43.0 (19.6) 
15.0 (9.1) 
48.8 (16.8) 
0 
188.5 (89.7) 
3.4 (1.6) 
0.4 (0.5) 
25.9 (5.9) 
2.6 (1.5) 
32.1 (9.2) 
22.9 (6.3) 
58.2 (12.7) 
64.4 (19.3) 
48.0 (2.7) 
31.2 (8.3) 
39.0 (5.7) 
13.5 (3.1) 
10.4 (3.9) 
54.7 (13.9) 
28.1 (5.6) 
39.3 (18.0) 
0.2 (0.5) 
85.2 (37.6) 
0.6 (0.9) 
0.3 (0.7) 
30.8 (5.6) 
4.0 (1.7) 
32.9 (7.6) 
25.8 (7.6) 
65.9 (22.0) 
76.7 (28.2) 
29.7 (7.5) 
26.6 (5.7) 
22.9 (6.2) 
 
Note. Time = time to completion; Seq. Errors = sequencing errors; LOS Errors = loss of set errors; RCFT = Rey Complex 
Figure Test; FLPS = Frontal Lobe Personality Scale. 
 
3.5. Self-report measures of dysexecutive behavior (Frontal Lobe Personality Scale) 
 
TR-OCD patients obtained significantly higher scores on self-report measures of executive dysfunction (U = 18.5, 
p< .001) and apathy (U = 48.5, p< .001) associated with frontal lobe syndromes relative to normative controls. 
Interestingly TR-OCD patients did not differ from controls on the measure of behavioral disinhibition (p = .17) (see 
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Table 2).  Group differences remained significant even after controlling for age. 
 
 
 
 
3.6. Direct comparisons to five healthy controls   
 
For a number of measures, TR-OCD patients were directly compared to five right-handed healthy controls (2 male, 
3 female) evaluated in our laboratory for a separate unpublished study.  TR-OCD patients and healthy controls were 
matched for gender and handedness and matched as closely as possible for age and educational level.  Mean age of 
the healthy control sample was 34.6 years (SD = 12.0) and healthy controls had completed 9.6 years of formal 
education (SD = 5.1) ranging from 5 to 16 years.     
 
TR-OCD and healthy control groups did not differ significantly on age, educational level, handedness, or gender 
composition; however, mean age of the five control subjects was approximately three years younger than TR-OCD 
patients and one control subject had one additional year of formal education relative to the matched TR-OCD 
patient.  Therefore, age and educational level were controlled during analyses of neurocognitive test performance 
described below. 
 
Groups differed significantly on self-report measures of social anxiety (U = 2.0, p = .032) and depressive (U = 0.0, p 
= .008) symptom severity with TR-OCD patients demonstrating substantially higher scores; however, group 
differences on schizotypal personality features were not significant (U = 10.0, p = .69).  TR-OCD patients obtained 
significantly higher scores on OCI subscales assessing symptom frequency over the past month for obsessional 
thinking (U = 0.0, p = .008), compulsive washing (U = 0.5, p = .008), checking (U = 1.0, p = .016), mental 
neutralizing (U = 1.5, p = .016), doubting (U = 1.0, p = .016), and total OCI frequency (past month) (U = 0.0, p = 
.008).  However, group differences on the ordering and hoarding subscales did not reach significance (U = 5.0, p = 
.15 and U = 5.5, p = .15).   
 
Group differences tests of executive control, visuospatial working memory, and information processing speed were 
significant with TR-OCD patients demonstrated performance deficits relative to controls (see Tables 3 and 4 for 
group means and SD). Group differences on Spatial Span backwards (F(1,6) = 8.35, p = .028), Trail Making Test 
part B (Trails B completion time, F(1,6) = 10.8, p = .016 and Trails B sequencing errors, F(1,6) = 9.55, p =.021) 
were significant.  Groups did not, however, differ on Trails B loss set errors (F(1,6)= 0.00, p = .98).  Groups also 
differed on Digit Symbol Coding (F(1,6) = 9.4, p = .022) and Symbol Search (F(1,6) = 9.2, p = .023). 
 
Group differences of tests of verbal working memory (Letter-Number Sequencing, F(1,6) = 3.5, p =.10), inhibitory 
control (Color-Word Interference conditions 3 and 4, with F(1,6) = 0.17, p = .69 and F(1,5) = 0.002, p = .96, 
respectively), visuoconstructive accuracy (RCFT copy accuracy, F(1,6) = 0.99, p = .35) and organization (RCFT 
copy organization, F(1,6) = 0.42, p = .53) were not significant.  Groups did not demonstrate significant performance 
differences on the Design Fluency Test condition one (number correct, F(1,6) = 1.7, p = .23; loss of set errors, 
F(1,6) = 0.006, p = .93; repetition errors, F(1,6) = 0.93, p = .37).  Group differences on Design Fluency condition 
two were significant for number of correct responses (F(1,6) = 9.6, p = .021) with TR-OCD patients generating 
fewer correct designs.  TR-OCD patients did not make significantly more loss of set or repetition errors during 
condition two with F(1,6) = 0.36, p = .57 and F(1,6) = 4.2, p = .086, respectively.  Note that subjects must inhibit a 
previously learned response pattern during condition two.  During the 3rd Design Fluency condition (i.e., the 
“switching” condition), group differences for number of correct responses (F(1,6) = 1.0, p = .33), loss of set errors 
(F(1,6) = 0.005, p = .94), and repetition errors (F(1,6)= 5.1, p = .064) were not significant.  Note that, contrary to 
expectation, TR-OCD patients made fewer repetition errors during all three Design Fluency conditions. 
 
It is important to note that non-significant group differences were in expected directions for most neurocognitive 
tests with TR-OCD patients obtaining lower scores and slower response times relative to healthy controls (see Table 
4).   
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Table 3. Dimensional Measures of Psychiatric Symptoms: Group Means (SD) 
 
Measure TR-OCD Healthy Control 
 
n 
OCI-Total Frequency 
 
5 
87.0 (27.0) 
 
5 
21.8 (14.6) 
OCI-Obsessional Thinking 16.8 (5.2) 3.6 (2.5) 
OCI-Compulsive Washing 
OCI-Checking 
OCI-Mental Neutralizing 
OCI-Ordering 
OCI-Doubting 
OCI-Hoarding 
SPQ-B-Total  
BDI-Total 
LSAS-Total 
18.6 (8.0) 
17.0 (7.8) 
10.6 (3.8) 
12.0 (5.1) 
6.0 (1.7) 
6.0 (4.7) 
11.4 (8.3) 
27.8 (12.9) 
106.0 (26.2) 
 
2.4 (2.7) 
3.2 (3.5) 
3.6 (2.9) 
6.0 (4.4) 
1.4 (1.6) 
1.6 (1.8) 
8.6 (1.1) 
1.4 (1.1) 
73.0 (16.9) 
 
Note. OCI =Obsessive-Compulsive Inventory; SPQ-B = Schizotypal Personality Questionnaire-B; BDI = Beck Depression 
Inventory; LSAS = Liebowitz Social Anxiety Scale. 
Table 4.Neurocognitive Tests: Group Means (SD) 
 
Measure TR-OCD Healthy Control 
 
n 
Spatial Span Forward 
 
5 
7.2 (1.3) 
 
5 
8.0 (1.2) 
Spatial Span Backward 4.2 (2.5) 7.6 (2.0) 
Spatial Span Total 
Letter-Number Sequencing 
Digit Symbol Coding 
Symbol Search 
Trail Making Test (part A) Time 
Trail Making Test (part A) Seq. Errors 
Trail Making Test (part B) Time 
Trail Making Test (part B) Seq. Errors 
Trail Making Test (part B) LOS Errors 
RCFT copy accuracy 
RCFT copy organization 
Design Fluency Trial 1 Correct 
Design Fluency Trial 1 LOS Errors 
Design Fluency Trial 1 Repetition Errors 
Design Fluency Trial 2 Correct 
11.4 (3.0) 
7.8 (4.4) 
43.0 (19.6) 
15.0 (9.1) 
48.8 (16.8) 
0 
188.5 (89.7) 
3.4 (1.6) 
0.4 (0.5) 
25.9 (5.9) 
2.6 (1.5) 
7.2 (4.1) 
0.4 (0.5) 
2.0 (2.0) 
6.8 (4.9) 
15.6 (3.2) 
10.2 (3.8) 
56.6 (23.0) 
19.8 (10.8) 
42.5 (16.4) 
0.6 (0.8) 
95.0 (42.1) 
0.6 (0.5) 
0.4 (0.8) 
29.2 (4.7) 
2.0 (1.0) 
10.4 (5.5) 
0.4 (0.5) 
3.6 (3.2) 
10.4 (5.3) 
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Design Fluency Trial 2 LOS Errors 
Design Fluency Trial 2 Repetition Errors 
Design Fluency Trial 3 Correct 
Design Fluency Trial 3 LOS Errors 
Design Fluency Trial 3 Repetition Errors 
Color-Word Interference Test 1 Time 
Color-Word Interference Test 2 Time 
Color-Word Interference Test 3 Time 
Color-Word Interference Test 4 Time 
0.6 (0.8) 
1.6 (0.8) 
5.6 (2.9) 
1.2 (1.3) 
0.6 
32.1 (9.2) 
22.9 (6.3) 
58.2 (12.7) 
64.4 (19.3) 
 
0.4 (0.8) 
4.8 (3.3) 
7.6 (3.7) 
1.4 (1.5) 
2.6 (1.8) 
29.2 (7.1) 
22.7 (5.5) 
54.8 (19.5) 
58.1 (15.5) 
 
Note. Time = time to completion; Seq. Errors = sequencing errors; LOS Errors = loss of set errors; RCFT = Rey Complex 
Figure Test. 
 
4. Discussion 
 
A number of TR-OCD patients met diagnostic criteria for major axis I disorders (particularly mood and anxiety 
disorders) as well as a broad range of personality disorders.  The latter finding is consistent with prior studies that 
showed that patients with OCD frequently present with personality disorders, particularly cluster A and C disorders 
(Aycicegi, Dinn, & Harris, 2004; Bejerot, Ekselius, & von Knorring, 1998; Diaferia et al., 1997; Matsunaga et al., 
1998; Mavissakalian, Hamann, & Jones, 1990; Rodrigues-Torres & Del Porto, 1995). 
TR-OCD and normative control and healthy control group differences on the SPQ-B were not significant.  
Interestingly, 3 of 5 TR-OCD patients had markedly elevated scores on the SPQ-B, while the remaining two 
obtained low scores well below the general population mean, a noteworthy finding given that early studies reported 
associations between treatment resistance and comorbid schizotypal personality. 
 
TR-OCD patients demonstrated significant performance deficits on neurocognitive tests of visuospatial working 
memory, visuoconstructive ability, and executive control as well as one test of processing speed, but not a second, 
relative to normative controls.  TR-OCD patients obtained substantially higher scores on two FLPS subscales 
assessing executive dysfunction and apathy relative to normative controls. 
 
TR-OCD patients and normative controls did not differ significantly on measures of verbal working memory, 
sequencing (Trails A), figure copy organization, inhibitory control, odor identification, and a self-report measure of 
disinhibition (FLPS). The finding that TR-OCD patients did not demonstrate impaired performance on the odor 
identification test was unexpected given that such tasks are considered to be sensitive indicators of orbitofrontal 
dysfunction and a substantial body of work (both neurocognitive testing and neuroimaging findings) has revealed 
that aberrant orbitofrontal function is associated with OCD. 
 
TR-OCD patients were directly compared to five healthy controls evaluated in our laboratory for a separate 
unpublished study. TR-OCD patients demonstrated significant performance deficits on tests of visuospatial working 
memory, processing speed, and executive control, and obtained substantially higher scores on dimensional measures 
of social anxiety and depressive symptom severity, but not schizotypal personality features. Group differences of 
tests of verbal working memory, inhibitory control, visuoconstructive accuracy and organization, and additional 
tests of executive function were not significant.  One seemingly counterintuitive finding was that healthy controls 
made a greater number of repetition errors during the Design Fluency Test across all three conditions.  This may 
represent greater level of adherence to rules among patients with OCD, which is consistent with the clinical 
presentation of the disorder. 
 
The principal limitation of the present study is, of course, TR-OCD sample size.   
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4.1. Conclusions   
 
TR-OCD patients demonstrated performance deficits on some, but not all, measures of working memory and 
executive control. Neurocognitive test findings lend partial support to the hypothesis that right hemisphere 
(particularly dorsolateral-prefrontal, but not orbitofrontal) dysfunction is associated with TR-OCD.  Interestingly, in 
a separate unpublished study we found that TR-OCD patients obtained significantly higher verbal intelligence 
scores (VIQ) relative to non-verbal intelligence (PIQ) scores. In the present study, patients with TR-OCD fulfilled 
criteria for a broad range of comorbid axis I conditions (primarily mood and anxiety disorders) and personality 
disorders further complicating treatment. 
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